HC&B Healthcare Communications makes appointment
This article was originally published in Scrip
HC&B Healthcare Communications (US) has promoted Amy Smith from group account supervisor to account director. In her new position, she will be leading the HC&B Clinical Division, which handles medical device, pharma and biotech accounts.
You may also be interested in...
The device can conduct laparoscopic hysterectomies, giving surgeons more mobility while leaving less scarring.
Nulibry obtains FDA approval weeks ahead of its action date. Although small patient base offers modest revenue opportunity, approval enables BridgeBio to get commercial operations underway.
Since raising $135m in 2017 to address rare, monogenic diseases, BridgeBio has launched or purchased 17 companies and built a pipeline of 30-plus candidates. Scrip checked in as the company nears commercialization.